+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNAi Therapeutics Market - Global Forecast 2025-2030- Product Image
RNAi Therapeutics Market - Global Forecast 2025-2030- Product Image
Sale

RNAi Therapeutics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6124468
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

RNA interference (RNAi) therapeutics represent a pivotal advancement in gene-silencing technologies, offering precise modulation of gene expression for challenging diseases. As global R&D accelerates, RNAi’s clinical and commercial potential continues to draw robust investment, innovation, and strategic collaboration across the biopharma landscape.

Market Snapshot of RNAi Therapeutics

The RNAi therapeutics market is experiencing significant expansion, driven by major advancements in delivery mechanisms, molecule design, and industry alliances. Recent regulatory traction and growing clinical pipelines across oncology, cardiovascular, metabolic, infectious, and rare diseases are broadening the applications of RNAi solutions. Strategic partnerships among biotech firms, academic centers, and multinational pharmaceutical companies are catalyzing faster advancement from early development to commercial launch. Enhanced regional manufacturing hubs, especially in North America, Western Europe, and Asia-Pacific, are notable for building supply resilience and supporting global market integration.

Scope & Segmentation

This comprehensive research analyzes the RNAi therapeutics landscape across multiple strategic dimensions:

  • Indication Areas: Cardiovascular disorders, infectious diseases, metabolic disorders, oncology (including hematological malignancies such as leukemia, lymphoma, myeloma; and solid tumors such as breast, liver, lung cancers), and rare diseases
  • Delivery Technologies: Exosome-based carriers, GalNAc conjugates, lipid nanoparticles, polymeric nanoparticles, viral vectors
  • Therapeutic Molecule Types: MicroRNA, short hairpin RNA, small interfering RNA
  • Development Stages: Commercial, Phases I, II, III, and preclinical
  • Routes of Administration: Intranasal, intravenous, intravitreal, subcutaneous
  • Formulation Types: Liquid, lyophilized
  • End Users: Academic institutions, hospitals, research laboratories, specialty clinics
  • Geographical Coverage: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, and Africa (examples: United Kingdom, Germany, France, Russia, United Arab Emirates, South Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
  • Key Companies Covered: Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Roche Holding AG, Novartis AG, Arbutus Biopharma, Silence Therapeutics, Benitec Biopharma, Quark Pharmaceuticals

Key Takeaways for Senior Decision-Makers

  • RNAi therapeutics leverage the cell’s innate gene-silencing pathways to enable targeted reduction of disease-causing genes, driving competitive differentiation in precision medicine portfolios.
  • Technological innovations—including advanced nanoparticle carriers and chemical modifications—are mitigating delivery challenges and immunogenicity risks, advancing candidates toward late-stage clinical milestones.
  • Emerging regulatory frameworks and recent product approvals are streamlining development timelines, encouraging expanded partnership structures between early-stage biotech firms and global pharmaceutical leaders.
  • Robust regional investment, especially within Asia-Pacific, is solidifying local production of delivery platforms and supporting scalable supply chain models for both preclinical and commercial assets.
  • Strategic emphasis is shifting toward operational agility: adaptive sourcing, nearshoring, and regional alliances are helping companies manage new cost structures and logistic complexities.

Tariff Impact: United States and Global Supply Chains

In 2025, the implementation of new United States tariffs on RNAi therapeutics’ raw materials and specialized equipment has triggered a broad reassessment of sourcing and development strategies. Increased duties on lipid formulations, polymeric carriers, and key reagents have raised costs and lengthened lead times. Manufacturers and research organizations are responding with alternative sourcing, domestic production, long-term vendor agreements, and enhanced inventory controls to protect supply continuity. This shift is influencing project prioritization, pricing models, and long-term partnership approaches throughout the RNAi value chain.

Research Methodology & Data Sources

This report employs a multi-phased research approach, combining secondary analysis of peer-reviewed publications, regulatory documents, clinical trial registries, and patents, with primary interviews of industry experts and senior executives. Data triangulation and independent validation across market intelligence platforms, follow-up expert discussions, and continuous peer review ensure reliable, actionable findings.

Why This Report Matters

  • Guides investment and strategic decisions by mapping segmented growth opportunities across technology platforms, indications, and regions.
  • Equips teams with in-depth market intelligence needed to optimize clinical pathways and commercial supply chain strategies under changing regulatory and policy conditions.

Conclusion

RNAi therapeutics continue to evolve as a foundational platform, offering advanced precision across diverse medical needs. Senior leaders can leverage sector analysis to build resilient, innovative, and future-ready RNAi strategies.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of novel chemical modifications to improve siRNA stability and reduce off-target effects in clinical pipelines
5.2. Adoption of lipid nanoparticle delivery platforms for targeted hepatocyte-specific RNAi therapies
5.3. Development of GalNAc conjugate-targeting strategies to enhance extrahepatic RNAi drug delivery efficiency
5.4. Expansion of RNAi therapeutic indications into oncology, metabolic disorders and fibrotic disease areas
5.5. Strategic partnerships between biotech innovators and CROs for large-scale RNAi manufacturing and quality control
5.6. Regulatory framework updates from FDA and EMA clarifying approval requirements for novel RNAi therapeutics
5.7. Emergence of personalized gene silencing approaches tailored to patient-specific mutations in rare diseases
5.8. Innovation in endosomal escape technologies to significantly improve intracellular uptake of RNAi molecules
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. RNAi Therapeutics Market, by Indication
8.1. Introduction
8.2. Cardiovascular Disorders
8.3. Infectious Diseases
8.4. Metabolic Disorders
8.5. Oncology
8.5.1. Hematological Malignancies
8.5.1.1. Leukemia
8.5.1.2. Lymphoma
8.5.1.3. Myeloma
8.5.2. Solid Tumors
8.5.2.1. Breast Cancer
8.5.2.2. Liver Cancer
8.5.2.3. Lung Cancer
8.6. Rare Diseases
9. RNAi Therapeutics Market, by Delivery Technology
9.1. Introduction
9.2. Exosomes
9.3. GalNAc Conjugates
9.4. Lipid Nanoparticles
9.5. Polymeric Nanoparticles
9.6. Viral Vectors
10. RNAi Therapeutics Market, by Therapeutic Molecule Type
10.1. Introduction
10.2. Microrna
10.3. Short Hairpin Rna
10.4. Small Interfering Rna
11. RNAi Therapeutics Market, by Development Stage
11.1. Introduction
11.2. Commercial
11.3. Phase I
11.4. Phase Ii
11.5. Phase III
11.6. Preclinical
12. RNAi Therapeutics Market, by Route of Administration
12.1. Introduction
12.2. Intranasal
12.3. Intravenous
12.4. Intravitreal
12.5. Subcutaneous
13. RNAi Therapeutics Market, by Formulation Type
13.1. Introduction
13.2. Liquid Formulation
13.3. Lyophilized Formulation
14. RNAi Therapeutics Market, by End User
14.1. Introduction
14.2. Academic Institutions
14.3. Hospitals
14.4. Research Laboratories
14.5. Specialty Clinics
15. Americas RNAi Therapeutics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa RNAi Therapeutics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific RNAi Therapeutics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Alnylam Pharmaceuticals, Inc.
18.3.2. Arrowhead Pharmaceuticals, Inc.
18.3.3. Roche Holding AG
18.3.4. Novartis AG
18.3.5. Arbutus Biopharma Corporation
18.3.6. Silence Therapeutics plc
18.3.7. Benitec Biopharma Limited
18.3.8. Quark Pharmaceuticals, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. RNAI THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RNAI THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. RNAI THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. RNAI THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. RNAI THERAPEUTICS MARKET: RESEARCHAI
FIGURE 30. RNAI THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 31. RNAI THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 32. RNAI THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RNAI THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RNAI THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RNAI THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LIVER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY EXOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY EXOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY GALNAC CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY GALNAC CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY POLYMERIC NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY POLYMERIC NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY MICRORNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY MICRORNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SHORT HAIRPIN RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SHORT HAIRPIN RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SMALL INTERFERING RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SMALL INTERFERING RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY INTRAVITREAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LYOPHILIZED FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY LYOPHILIZED FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RNAI THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES RNAI THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 145. CANADA RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 148. CANADA RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 149. CANADA RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 150. CANADA RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 151. CANADA RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 152. CANADA RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 153. CANADA RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. CANADA RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. CANADA RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 158. CANADA RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 159. CANADA RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. CANADA RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. CANADA RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. CANADA RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 170. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 171. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 183. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 270. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 271. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 272. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 273. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 280. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 284. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 285. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. GERMANY RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 290. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 291. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 292. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 293. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 300. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 301. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 304. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 305. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. FRANCE RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY THERAPEUTIC MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA RNAI THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. ITALY RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. ITALY RNAI THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. ITALY RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 330. ITALY RNAI THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 331. ITALY RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 332. ITALY RNAI THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 333. ITALY RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 334. ITALY RNAI THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 335. ITALY RNAI THERAPEUTICS MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this RNAi Therapeutics market report include:
  • Alnylam Pharmaceuticals, Inc.
  • Arrowhead Pharmaceuticals, Inc.
  • Roche Holding AG
  • Novartis AG
  • Arbutus Biopharma Corporation
  • Silence Therapeutics plc
  • Benitec Biopharma Limited
  • Quark Pharmaceuticals, Inc.

Related Topics

Related Reports

Antisense & RNAi Therapeutics Market - Global Forecast 2025-2030 - Product Image

Antisense & RNAi Therapeutics Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Antisense & RNAi Therapeutics Market Report by Technology, Route of Administration, Application, and Region 2025-2033 - Product Image

Antisense & RNAi Therapeutics Market Report by Technology, Route of Administration, Application, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Antisense & RNAi Therapeutics - A Global Market Overview - Product Image

Antisense & RNAi Therapeutics - A Global Market Overview

  • Report
  • 253 Pages
  • Global
From
Antisense & RNAi Therapeutics Market Report 2025 - Product Image

Antisense & RNAi Therapeutics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
RNAi Drug Delivery - Global Strategic Business Report - Product Image

RNAi Drug Delivery - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.